(+/-)-3'-acetyl-3',5',8',11'-tetraaza-11'-(6-chloronaphthalen-2-ylsulfonyl)-1-(2-oxazolinyl) spiro[piperidine-4,6'-tricyclo[6.4.0.0(1,5)]dodecan]-9'-one | 958448-32-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 英文名称: (+/-)-3'-acetyl-3',5',8',11'-tetraaza-11'-(6-chloronaphthalen-2-ylsulfonyl)-1-(2-oxazolinyl) spiro[piperidine-4,6'-tricyclo[6.4.0.0(1,5)]dodecan]-9'-one
• 英文别名: 3-Acetyl-11-(6-chloronaphthalen-2-yl)sulfonyl-1'-(4,5-dihydro-1,3-oxazol-2-yl)spiro[3,5,8,11-tetrazatricyclo[6.4.0.01,5]dodecane-6,4'-piperidine]-9-one
• CAS: 958448-32-3
• 化学式: C₂₇H₃₁ClN₆O₅S
• 分子量: 587.099
• InChiKey: NDJWJFIKNJDFRB-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  40
• 可旋转键数：
  3
• 环数：
  7.0
• sp3杂化的碳原子比例：
  0.52
• 拓扑面积：
  114
• 氢给体数：
  0
• 氢受体数：
  8

文献信息

• Spiro Tetracyclic Compound
  申请人：Nishida Hidemitsu

  公开号：US20090170844A1

  公开（公告）日：2009-07-02

  Disclosed is an anti-coagulant which has extremely excellent inhibitory effect on FXa and an extremely poor inhibitory effect on hERG channel, and can be administered through the oral route. Specifically, disclosed is a compound represented by the formula (I) or a pharmaceutically acceptable salt thereof.